Routine arrhythmia inductions for ICD follow-up: Are they obsolete?

PACE - Pacing and Clinical Electrophysiology

Volumn 24, Issue 6, 2001, Pages 915-920

  Glikson, Michael ^a,b,c   Friedman, Paul ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b MAYO CLINIC   (United States)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DEFIBRILLATION; DEFIBRILLATOR; EDITORIAL; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN;

EID: 0034912021     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2001.00915.x     Document Type: Editorial

References (46)

1. Implantable cardioverter defibrillators in cardiovascular practice: Report of the policy conference of the North American Society of Pacing and Electrophysiology
2. High failure rate for an epicardial implantable cardioverter-defibrillator lead: Implications for long-term follow-up of patients with an implantable cardioverter-defibrillator
3. The pacer-cardioverter-defibrillator: Function and clinical experience
4. Failures of epicardial and transvenous leads for implantable cardioverter defibrillators
5. Experience with pectoral versus abdominal implantation of a small defibrillator. A multicenter comparison in 778 patients
6. A prospective randomized cross-over comparison of mono- and biphasic defibrillation using nonthoracotomy lead configurations in humans
7. Clinical experience with a new cardioverter defibrillator capable of biphasic waveform pulse and enhanced data storage: Results of a prospective multicenter study
8. A prospective randomized evaluation of biphasic versus monophasic waveform pulses on defibrillation efficacy in humans
9. A multicenter, randomized trial comparing an active can implantable defibrillator with a passive can system
10. Prospective, randomized comparison in humans of a unipolar defibrillation system with that using an additional superior vena cava electrode
11. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator
12. Rise in chronic defibrillation energy requirements necessitating implantable defibrillator lead system revision
13. Early postoperative increase in defibrillation threshold with nonthoracotomy system in humans
14. Chronic rise in monophasic defibrillation thresholds with a transvenous lead system
15. Rise in chronic defibrillation thresholds in nonthoracotomy implantable defibrillator
16. Early postoperative rise in defibrillation threshold in patients with nonthoracotomy defibrillation lead systems: Attenuation with biphasic shock waveforms
17. Increase in defibrillation threshold in non-thoracotomy implantable defibrillators using a biphasic waveform
18. Temporal stability of defibrillation thresholds with an active pectoral lead system
19. Utility of predischarge and one-month transvenous implantable defibrillator tests
20. Predischarge arrhythmia induction testing of implantable defibrillators may be unnecessary in selected cases
21. Is there a need for routine testing of ICD defibrillation capacity? Results from more than 1000 studies
22. Late retesting of system performance in ICD patients without spontaneous shocks
23. Biphasic waveforms prevent the chronic rise of defibrillation thresholds with a transvenous lead system
24. Stability of long term defibrillation thresholds in patients with nonthoracotomy implantable defibrillators
25. Are routine arrhythmia inductions necessary in patients with pectoral implantable cardioverter defibrillators?
26. Is predismissal ICD defibrillation threshold testing necessary?
27. On the necessity of the invasive predischarge test after implantation of a cardioverter-defibrillator
28. A stepwise testing protocol for modern implantable cardioverter-defibrillator systems to prevent pacemaker-implantable cardioverter-defibrillator interactions
29. ICD restudy: Results and potential benefit from routine predischarge and 2-month evaluation
30. Multicenter evaluation of implantable cardioverter defibrillator testing after implant: The post implant testing study (PITS)
31. Defibrillator challenges for the new millenium: The marriage of device and patient-making and maintaining a good match
32. Long-term survival and complications in patients with malignant ventricular tachyarrhythmias: Treatment with a nonthoracotomy implantable cardioverter defibrillator with or without a subcutaneous patch
33. High frequency of late endovascular lead malfunction in implantable defibrillator: Predictors and mode of detection of transvenous lead malfunction in implantable defibrillators
34. Transvenous cardioverter defibrillator lead malfunction due to terminal connector damage in pectoral implants
35. Sensing lead failure in implantable defibrillators: A comparison of two commonly used leads
36. Sensing lead-related complications in patients with transvenous implantable cardioverter-defibrillators
37. Patient alert: Clinical experience with a new patient monitoring system in a dual chamber defibrillator
38. Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: A prospective study including 200 patients
39. ICD-antiarrhythmic drug and ICD-pacemaker interactions
40. Effects of amiodarone and its active metabolite desethylamiodarone on the ventricular defibrillation threshold
41. Effects of antiarrhythmic drugs on epicardial defibrillation energy requirements and the rate of defibrillator discharges
42. Effects of chronic amiodarone therapy on defibrillation threshold
43. Drug and defibrillator interactions
44. Effect of amiodarone and sotalol on the defibrillation threshold in comparison to patients without antiarrhythmic drug treatment
45. Interactions between implantable cardioverter-defibrillators and class III agents
46. Follow up